These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11898504)

  • 1. Progress in gene therapy for Duchenne muscular dystrophy.
    Clemens PR; Duncan FJ
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):89-96. PubMed ID: 11898504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utrophin therapy for Duchenne muscular dystrophy?
    Nelson R
    Lancet Neurol; 2004 Nov; 3(11):637. PubMed ID: 15515235
    [No Abstract]   [Full Text] [Related]  

  • 3. Utrophin upregulation in Duchenne muscular dystrophy.
    Hirst RC; McCullagh KJ; Davies KE
    Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
    Perkins KJ; Davies KE
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.
    Fairclough RJ; Wood MJ; Davies KE
    Nat Rev Genet; 2013 Jun; 14(6):373-8. PubMed ID: 23609411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapies for Duchenne muscular dystrophy.
    Kapsa R; Kornberg AJ; Byrne E
    Lancet Neurol; 2003 May; 2(5):299-310. PubMed ID: 12849184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
    Wells DJ; Wells KE
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy for Hemophilia and Duchenne Muscular Dystrophy in China.
    Liu X; Liu M; Wu L; Liang D
    Hum Gene Ther; 2018 Feb; 29(2):146-150. PubMed ID: 29366352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
    Blankinship MJ; Gregorevic P; Chamberlain JS
    Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy.
    Wong TWY; Cohn RD
    Curr Gene Ther; 2017; 17(4):301-308. PubMed ID: 29173172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.
    Bogdanovich S; Perkins KJ; Krag TO; Khurana TS
    J Mol Med (Berl); 2004 Feb; 82(2):102-15. PubMed ID: 14673527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic therapeutic approaches for Duchenne muscular dystrophy.
    Foster H; Popplewell L; Dickson G
    Hum Gene Ther; 2012 Jul; 23(7):676-87. PubMed ID: 22647146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the use of gene therapy to treat Duchenne muscular dystrophy.
    Jarmin S; Kymalainen H; Popplewell L; Dickson G
    Expert Opin Biol Ther; 2014 Feb; 14(2):209-30. PubMed ID: 24308293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant micro-genes and dystrophin viral vectors.
    Dickson G; Roberts ML; Wells DJ; Fabb SA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S40-4. PubMed ID: 12206793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients.
    Duan D
    Hum Gene Ther; 2018 Jul; 29(7):733-736. PubMed ID: 29463117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic and genetic therapy for childhood muscular dystrophies.
    Escolar DM; Scacheri CG
    Curr Neurol Neurosci Rep; 2001 Mar; 1(2):168-74. PubMed ID: 11898513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the path to a Duchenne muscular dystrophy therapy.
    Fallon J
    R I Med J (2013); 2013 Feb; 96(2):22-5. PubMed ID: 23641422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.